Skip to content

Young People, ART and Adherence (YPAA) Trial

Young People, ART and Adherence

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202307473009904
Enrollment
200
Registered
2023-07-17
Start date
2023-08-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Standard of care

Sponsors

London School of Hygiene and Tropical Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 16-24 years. 2. Taking ART for at least 6 months 3. Custodian of a mobile phone to prevent inadvertent HIV disclosure and able to receive text messages on the mobile phone 4. VL result >200 copies/ml taken within the last six months. If no recent viral load done within the last six months a viral load sample will be collected as part of screening. 5. A firm home address in Greater Harare accessible for visiting and intending to remain there for 9 months 6. Positive HIV status known by participant 7. Consenting to participate in the study and to give blood samples

Exclusion criteria

Exclusion criteria: 1. Any condition (except HIV) that may prove fatal during the study period (e.g. malignancy, end-stage HIV disease or other conditions deemed likely fatal by the principal investigator). 2. Conditions likely to lead to lack of understanding of study procedures or to uncooperative behaviour e.g. neurocognitive disease, developmental delay, psychiatric illness or any other illness that may result in failure to understand study procedures (based on clinical assessment). 3. Living in the same household as a trial participant (to avoid inadvertent mix-up of intervention components) 4. Concurrent participation in other interventional studies addressing adherence

Design outcomes

Primary

MeasureTime frame
Proportion of participants with suppressed viral load (<50 copies/ml)

Secondary

MeasureTime frame
Proportion of participants with viral load 200 copies/ml) at 9 months;Change in proportion of participants with GRT mutations;Number of antiretroviral therapy regimen switches;Mean adherence to ART as measured by the EMD - intervention participants only;Adherence behaviour patterns using machine learning techniques;Mean adherence to ART as measured by pill count, self-report and pharmacy refill

Countries

Zimbabwe

Contacts

Public ContactMufaro Makuni

Communications and public engagement officer

mufaronashe@gmail.com+263774153146

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026